Abstract
摘要
相似文献
1
Adderall: the newest available option in ADHD.安非他明：治疗注意力缺陷多动障碍的最新可用药物。
Adv Nurse Pract. 1997 Jun;5(6):73-4.
2
Adderall and other drugs for attention-deficit/hyperactivity disorder.安非他命及其他用于治疗注意力缺陷多动障碍的药物。
Med Lett Drugs Ther. 1994 Nov 25;36(936):109-10.
3
Inconclusive evidence puts Adderall back on the market.证据不确凿，安非他命重回市场。
CMAJ. 2005 Oct 11;173(8):858. doi: 10.1503/cmaj.051145.
4
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.注意缺陷多动障碍儿童和青少年中枢神经系统兴奋剂制剂的最新情况
Ann Pharmacother. 2009 Jun;43(6):1084-95. doi: 10.1345/aph.1L523. Epub 2009 May 26.
5
Adderall, the atypicals, and weight gain.阿得拉、非典型药物与体重增加。
J Am Acad Child Adolesc Psychiatry. 2001 Jun;40(6):620. doi: 10.1097/00004583-200106000-00004.
6
Stimulant therapy in attention deficit/hyperactivity disorder.注意缺陷/多动障碍的兴奋剂治疗
J Ark Med Soc. 2003 Dec;100(6):203-6.
7
Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.混合安非他明盐缓释剂（阿得拉XR）治疗青少年注意缺陷多动障碍的疗效与安全性：一项为期4周的随机、双盲、安慰剂对照平行组研究。
Clin Ther. 2006 Feb;28(2):266-79. doi: 10.1016/j.clinthera.2006.02.011.
8
9
Age-related changes in motor subtle signs among girls and boys with ADHD.
Neurology. 2009 Oct 13;73(15):1248; author reply 1248-9. doi: 10.1212/WNL.0b013e3181b26eb6.
10
Adderall XR: long acting stimulant for single daily dosing.安非他命长效缓释片：每日单次服用的长效兴奋剂。
Expert Rev Neurother. 2004 Nov;4(6):927-34. doi: 10.1586/14737175.4.6.927.
Zotero 插件